Replies to post #133580 on Biotech Values

[Biowatch]

It's in regards to the biosimilars comment:
"FDA Plans Biosimilars Development Meeting Guidance in 2014 "
which seems like kicking the can down the road, and past the expiration date for several patents.
Agreeing to begin to discuss an issue is not the same as planning to make a decision.
#msg-70177745